Clinical analysis of speculum-based vaginal packing for high-dose-rate intracavitary tandem and ovoid brachytherapy in cervical cancer

被引:6
|
作者
Sud, Shivani [1 ]
Roth, Toni [2 ]
Jones, Ellen [3 ]
机构
[1] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[2] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA
[3] Univ North Carolina Chapel Hill, Dept Radiat Oncol, Chapel Hill, NC USA
关键词
intracavitary brachytherapy; cervical cancer; rectal dose; bladder dose; speculum; retractor; LATE RECTAL COMPLICATIONS; VOLUME PARAMETERS; SPACER BALLOON; CARCINOMA; REDUCTION; RECOMMENDATIONS; RADIOTHERAPY; RETRACTOR; CISPLATIN; TERMS;
D O I
10.5114/jcb.2018.74316
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Intra-vaginal packing is used to fix the applicator and displace organs at risk (OAR) during high-doserate intracavitary tandem and ovoid brachytherapy (HDR-ICB). We retain the speculum from applicator placement as a dual-function bladder and rectum retractor during treatment. Our objective is to review salient techniques for OAR displacement, share our packing technique, and determine the reduction in dose to OAR and inter-fraction variability of dose to OAR, associated with speculum-based vaginal packing (SBVP) in comparison to conventional gauze packing during HDR-ICB. Material and methods: We reviewed HDR-ICB treatment plans for 45 patients, including 10 who underwent both conventional gauze packing and SBVP. Due to institutional inter-provider practice differences, patients non-selectively received either packing procedure. Packing was performed under conscious sedation, followed by cone beam computed tomography used for dosimetric planning. Maximum absolute and percent-of-prescription dose to the International Commission of Radiation Units bladder and rectal points in addition to D-0.1cc, D-1.0cc, and D-2.0cc volumes of the bladder and rectum were analyzed and compared for each packing method using an independent sample t-test. Results: Of the 179 fractions included, 73% and 27% used SBVP and gauze packing, respectively. For patients prescribed 6 Gy to point A, SBVP was associated with reduced mean D-0.1cc bladder dose, inter-fraction variability in D-0.1cc bladder dose by 9.3% (p = 0.026) and 9.0%, respectively, and statistically equivalent rectal D-0.1cc, D-1.0cc, and D-2.0cc. Patients prescribed 5.5 Gy or 5 Gy to point A after dose optimization, were less likely to benefit from SBVP. In the intra- patient comparison, 80% of patients had reduction in at least one rectum or bladder parameter. Conclusions: In patients with conducive anatomy, SBVP is a cost-efficient packing method that is associated with improved bladder sparing and comparable rectal sparing relative to gauze packing during HDR-ICB without general anesthesia.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [41] Image Guided Radiation Therapy Boost in Combination With High-Dose-Rate Intracavitary Brachytherapy for the Treatment of Cervical Cancer
    Wang, X.
    Wang, P.
    Li, J.
    Yuan, K.
    Yin, G.
    Wan, B.
    Lang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E306 - E306
  • [42] Severe Gastrointestinal Complications in the Era of Image-guided High-dose-rate Intracavitary Brachytherapy for Cervical Cancer
    Trifiletti, Daniel M.
    Watkins, W. Tyler
    Duska, Linda
    Libby, Bruce B.
    Showalter, Timothy N.
    CLINICAL THERAPEUTICS, 2015, 37 (01) : 49 - 60
  • [43] MRI-Guided High-Dose-Rate Intracavitary Brachytherapy for Treatment of Cervical Cancer: The University of Pittsburgh Experience
    Gill, Beant S.
    Kim, Hayeon
    Houser, Christopher J.
    Kelley, Joseph L.
    Sukumvanich, Paniti
    Edwards, Robert P.
    Comerci, John T.
    Olawaiye, Alexander B.
    Huang, Marilyn
    Courtney-Brooks, Madeleine
    Beriwal, Sushil
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 91 (03): : 540 - 547
  • [44] Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer
    Kubicky, Charlotte Dai
    Yeh, Benjamin M.
    Lessard, Etienne
    Joe, Bonnie N.
    Speight, Joycelyn L.
    Pouliot, Jean
    Hsu, I-Chow
    BRACHYTHERAPY, 2008, 7 (03) : 242 - 247
  • [45] American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer
    Mayadev, Jyoti
    Viswanathan, Akila
    Liu, Yu
    Li, Chin-Shang
    Albuquerque, Kevin
    Damato, Antonio L.
    Beriwal, Sushil
    Erickson, Beth
    BRACHYTHERAPY, 2017, 16 (01) : 22 - 43
  • [46] Rectal and bladder dose reduction with the addition of intravaginal balloons to vaginal packing in intracavitary brachytherapy for cervical cancer
    Eng, T. Y.
    Patel, A. J.
    Ha, C. S.
    BRACHYTHERAPY, 2016, 15 (03) : 312 - 318
  • [47] Point A or point H in prescribing high-dose-rate (HDR) intracavitary brachytherapy for cervical carcinoma?
    Eng, T. Y.
    Cummins, S.
    Baake, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S396 - S397
  • [48] Comparison of high-dose-rate intracavitary brachytherapy dosimetry with and without anesthesia in patients with cervical carcinoma
    Sharma, Daya N.
    Chaudhari, Pritee
    Sharma, Seema
    Gupta, Leena
    Jagadesan, Pandjatcharam
    Rath, Goura K.
    Julka, Pramod K.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2014, 15 (02): : 60 - 66
  • [49] Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer
    Wang, CJ
    Huang, EY
    Sun, LM
    Chen, HC
    Fang, FM
    Hsu, HC
    Changchien, CC
    Leung, SW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01): : 179 - 189
  • [50] Attention 3D UNET for dose distribution prediction of high-dose-rate brachytherapy of cervical cancer: Intracavitary applicators
    Gautam, Suman
    Osman, Alexander F. I.
    Richeson, Dylan
    Gholami, Somayeh
    Manandhar, Binod
    Alam, Sharmin
    Song, William Y.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2025, 26 (02):